Does reduced gastric acid (hypochlorhydria) promote survival of ingested microbes and increase SIBO risk?

The gastric acid barrier acts as a critical biological gatekeeper, protecting the lower gastrointestinal tract from ingested microbes. When gastric acidity is compromised, this protective barrier fails, allowing microbial survival and downstream colonization.

Clinical evidence and SIBO risk

• Increased SIBO risk: Clinical data using proton-pump inhibitor (PPI)-induced acid suppression as a proxy demonstrates that hypochlorhydria significantly increases the risk of small intestinal bacterial overgrowth (SIBO).
• Key study metrics: A comprehensive 2025 meta-analysis of 29 studies showed that PPI-induced hypochlorhydria doubles the risk of developing SIBO, with a pooled odds ratio (OR) of 2.143.
• Duration-response relationship: The analysis established a clear duration-response curve, showing a 4.265% absolute increase in SIBO prevalence for each additional month of acid-suppressive therapy. Consensus guidelines now recommend deprescribing or step-down therapy when SIBO is a concern.

Mechanistic explanations

• Loss of bactericidal efficacy: In a healthy fasting state, gastric juice maintains a highly acidic environment (pH 1–2). Exposing vegetative bacteria to a pH below 3–4 results in a rapid, near-complete (99.9%) reduction in microbial viability within 30 minutes.
• Permissive threshold: When gastric pH rises to 4 or higher (hypochlorhydria), this bactericidal effect is lost, permitting ingested bacteria, yeasts, and fungal spores to survive transit unharmed.
• Microbial translocation: Surviving microbes from the mouth and upper respiratory tract translocate downstream, altering duodenal diversity and shifting the distal gut microbiome.
• Horizontal gene transfer: Elevated gastric pH under hypochlorhydric conditions has been shown to enhance the horizontal transfer of multidrug-resistance plasmids (such as RP4) among enteric bacteria in simulated gastric fluid.

Bottom line

• Hypochlorhydria compromises the gastric acid barrier by raising pH above the critical bactericidal threshold (pH 3–4), which directly enables oral-gut microbial translocation and is associated with a more than twofold increase in SIBO risk.